Level C· Early human research exploring benefitsProspective StudyPubMedOpen access

Sequential Applications of Adipose Tissue-derived Stem Cells Enhance Healing in Complex Wounds: Experimental Model.

Pagotto VPF., Cacere PV., Altran SC., Dantas VANC., Furuya TK., Santos DLS.

Prospective Study on Chronic Wound, Immune Modulation, Autoimmune Research, published in Plast Reconstr Surg Glob Open (2025) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Plast Reconstr Surg Glob Open (2025)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
40291637
PMCID
PMC12026421
DOI
10.1097/GOX.0000000000006718
Citations
1

Abstract (original English)

Background Complex wounds represent a challenge to global health, incurring significant healthcare costs and compromising patients' quality of life. Recently, research has investigated the potential of adipose tissue-derived stem cells (ASC) for therapeutic stem cells' immunomodulatory properties. This study aimed to evaluate the effect of sequential applications of ASC in an experimental model of a complex wound. Methods Thirty male Wistar rats were subjected to a complex wound model of enterocutaneous fistula. After 4 weeks, the rats were divided into 3 groups: control, 2 applications of culture medium, and 2 applications of 1 × 10 6 allogeneic ASC. The animals were euthanized and analyzed 4 weeks after the first application regarding the macroscopic reduction of the wound, histopathologic changes, and gene expression related to wound healing ( Cd68 , Il1rap , Il10 , Mmp3 , Mmp9 , and Tnf ). Results Animals treated with ASC showed a reduction in wound diameter of 68% compared with the control group ( P = 0.002) and a reduction of 65% compared with the culture medium group ( P = 0.011). The ASC group also showed a more than 100% increase in blood vessel count compared with the control group ( P = 0.02). Gene expression analysis showed a decrease in the Mmp9 levels in the ASC group compared with the control group. Conclusions This study demonstrated that the treatment with ASC

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research